Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches

Area of Science:

• Cardiology
• Mitochondrial Biology
• Biochemistry

Background:

• Mitochondria are vital for cardiac homeostasis, regulating energy production, calcium handling, reactive oxygen species (ROS), and apoptosis.
• Impaired mitochondrial function is implicated in the development and progression of chronic heart failure (CHF).
• Mitochondrial dysfunction is a significant factor in cardiac pathophysiology and a potential therapeutic target for CHF.

Purpose of the Study:

• To review current knowledge on mitochondrial modulation as a therapeutic strategy for CHF.
• To explore future research perspectives in targeting mitochondrial dysfunction for CHF treatment.

Main Methods:

• A literature search was conducted on Medline and Scopus for original articles and reviews.
• The search focused on the treatment of mitochondrial dysfunction specifically in the context of CHF.

Main Results:

• Mitochondrial dysfunction in CHF is linked to neuro-humoral activation and cardiac remodeling.
• Enhancing glucose metabolism and reducing mitochondrial oxidative stress are promising therapeutic avenues for CHF.
• Other strategies like apoptosis inhibition and calcium normalization require further investigation, primarily in non-CHF or ex vivo models.

Conclusions:

• Mitochondrial modulation presents a novel and potentially effective therapeutic approach for chronic heart failure.
• This field represents an exciting area of translational research with significant potential for improving CHF treatment.